References
- Paulo C, Mourão C, Veiga PM, . Retrospective analysis of clinical yeast isolates in a hospital in the centre of Portugal: spectrum and revision of the identification procedures. Med Mycol 2009; 47: 836–844.
- Pospisil L. The significance of Candida pulcherrima findings in human clinical specimens. Mycoses 1989; 32: 581–583.
- Mohl W, Lerch MM, Klotz M, Freidank H, Zeitz M. Infection of an intravenous port system with Metschnikowia pulcherrima Pitt et Miller. Mycoses 1998; 41: 425–426.
- Mizuta M, Mizuta W, Tojyo K. A case of acute diffuse moniliasis presumably caused by Candida pulcherrima. Bull Yamaguchi Med School 1955; 3: 11–17.
- Linton CJ, Borman AM, Cheung G, . Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United Kingdom Mycology Reference Laboratory. J Clin Microbiol 2007; 45: 1152–1158.
- Seifert H, Aurbach U, Stefanik D, Cornely O. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates. Antimicrob Agents Chemother 2007; 51: 1818–1821.
- Weber A, Kolb S. The repeated isolation of Candida pulcherrima (Lindner) Windisch from blood cultures of a patient on parenteral nutrition. Mykosen 1986; 29: 127–131.
- Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard CLSI Document M27-A3. Wayne, PA:Clinical and Laboratory Standards Institute, 2008.
- White TJ, BrunsT, Lee S, TailorS. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innins MA, Gelfand DH, Sninsky JJ, White TJ (eds). PCR Protocols. A Guide To Methods And Applications. San Diego, CA: Academic Press, Inc., 1990: 315–322.
- Pitt JI, Miller MW. Sporulation in Candida pulcherrima, Candida reukaufii and Chlamydozyma species: their relationships with Metschnikowia. Mycologia 1968; 60: 663–685.
- Mandras N, Tullio V, Allizond V, . In vitro activities of fluconazole and voriconazole against clinical isolates of Candida spp. determined by disk diffusion testing in Turin, Italy. Antimicrob Agents Chemother 2009; 53: 1657–1659.
- Messer SA, Kirby JT, Sader HS, Fritsche TR, Jones RN. Initial results from a longitudinal international surveillance programme for anidulafungin (2003). J Antimicrob Chemother 2004; 54: 1051–1056.